Karen Bush

Karen Bush studies how bacteria resist antibiotics, with a particular focus on β-lactamases—enzymes that bacteria produce to break down common antibiotics like penicillins and carbapenems. The research covers how these enzymes are classified and named, how they spread, and how new drug combinations (such as antibiotics paired with β-lactamase inhibitors) can overcome resistant infections. Much of the work reviews and evaluates antibacterial agents in clinical development.

Publication activity has slowed over the last decade, dropping from around nine papers per year in 2017 to roughly two to four in recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Typically publishes in teams of ~2 · 56% small-team papers (≤3 authors) · across 18 venues